Skip to main content
All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for ZOETIS · Issues related to animal health including livestock and companion drugs and vaccines

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$80,000.00
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Lobbyists on this filing 4
  • CHRISTOPHER E. WILCOX
    Previously held: LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
  • LAURA M SIMMONS
    Previously held: Advisor, Office of Legislative Affairs, Dept of Homeland Security
  • JEANNE HAGGERTY
    Previously held: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
  • JOSHUA DAVID FENDRICK
    Previously held: Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 3
  • Executive Office of the President (EOP)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 4
Health Issues

Animal health, issues impacting medicines and vaccines for animals.

Taxation/Internal Revenue Code

Issues related to general corporate taxation; and implementation of PL 119-21.

Agriculture

General agricultural issues important to livestock producers, animal health and related policy issues. Issues impacting medicines and vaccines for animals.

Trade (domestic/foreign)

Monitor trade issues including those under section 301 of the Trade Act of 1974, USMCA. Monitor trade issues and supply chain issues related to veterinary pharmaceuticals and active ingredients. Potential tariff actions under Section 232 of the Trade Act of 1962.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem